{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:54:31Z","timestamp":1791399271955,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","psychosomaticsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.psym.2018.03.009","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T23:30:19Z","timestamp":1521675019000},"page":"341-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Considerations in Treating Insomnia During Pregnancy: A Literature Review"],"prefix":"10.1016","volume":"59","author":[{"given":"Simriti K.","family":"Chaudhry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah C.","family":"Susser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.psym.2018.03.009_bib1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/jmwh.12004","article-title":"Common sleep disorders: management strategies and pregnancy outcomes","volume":"58","author":"Nodine","year":"2013","journal-title":"J Midwifery Womens Health"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.psychres.2013.08.017","article-title":"Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial","volume":"210","author":"Khazaie","year":"2013","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.psym.2018.03.009_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-134-5-200103060-00012","article-title":"Sleep and sleep disorders in pregnancy","volume":"134","author":"Santiago","year":"2001","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.psym.2018.03.009_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0301-2115(01)00545-0","article-title":"A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy","volume":"101","author":"Eros","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.psym.2018.03.009_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00016347409156903","article-title":"Diazepam in early human pregnancy","volume":"53","author":"Erkkola","year":"1974","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"10","key":"10.1016\/j.psym.2018.03.009_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/bja\/51.10.971","article-title":"A study of the plasma concentrations of lorazepam in mother and neonate","volume":"51","author":"McBride","year":"1979","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.psym.2018.03.009_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/pds.1288","article-title":"Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study","volume":"16","author":"Kjaer","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.psym.2018.03.009_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00004714-200108000-00017","article-title":"Maternal exposure to lorazepam and anal atresia in newborns: results from a hypothesis-generating study of benzodiazepines and malformations","volume":"21","author":"Bonnot","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.psym.2018.03.009_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ije\/4.1.37","article-title":"Associations between oral clefts and drugs taken during pregnancy","volume":"4","author":"Saxen","year":"1975","journal-title":"Int J Epidemiol"},{"issue":"7933","key":"10.1016\/j.psym.2018.03.009_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(75)90548-6","article-title":"Association between cleft lip with or without cleft palate and prenatal exposure to diazepam","volume":"2","author":"Safra","year":"1975","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.psym.2018.03.009_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pds.1457","article-title":"Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations","volume":"16","author":"Wikner","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.psym.2018.03.009_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/bdrb.20144","article-title":"Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data","volume":"83","author":"Oberlander","year":"2008","journal-title":"Birth Defects Res B"},{"issue":"6","key":"10.1016\/j.psym.2018.03.009_bib13","doi-asserted-by":"crossref","first-page":"e100996","DOI":"10.1371\/journal.pone.0100996","article-title":"First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study","volume":"9","author":"Ban","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.psym.2018.03.009_bib14","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.4088\/JCP.14m09241","article-title":"Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children","volume":"77","author":"Pedersen","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.psym.2018.03.009_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ntt.2004.03.009","article-title":"A population-based case-control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities","volume":"26","author":"Czeizel","year":"2004","journal-title":"Neurotoxicol Teratol"},{"issue":"4","key":"10.1016\/j.psym.2018.03.009_bib16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ajog.2014.10.1106","article-title":"A review of sleep-promoting medications used in pregnancy","volume":"212","author":"Okun","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.psym.2018.03.009_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00044011-200323070-00004","article-title":"Short-term oral diazepam treatment during pregnancy: a population-based teratological case-control study","volume":"23","author":"Czeizel","year":"2003","journal-title":"Clin Drug Invest"},{"issue":"8031","key":"10.1016\/j.psym.2018.03.009_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(77)92855-0","article-title":"Floppy infant syndrome and maternal diazepam","volume":"2","author":"Gillberg","year":"1977","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.psym.2018.03.009_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3476(77)80785-3","article-title":"Withdrawal symptoms in neonates from intrauterine exposure to diazepam","volume":"90","author":"Rementeria","year":"1977","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.psym.2018.03.009_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/appi.ajp.2015.14080989","article-title":"The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month","volume":"173","author":"Salisbury","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.psym.2018.03.009_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.06.061","article-title":"Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy","volume":"201","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.psym.2018.03.009_bib22","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1176\/appi.ajp.2015.14121575","article-title":"Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data","volume":"172","author":"Malm","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.psym.2018.03.009_bib23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamapsychiatry.2017.2733","article-title":"Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes","volume":"74","author":"Yonkers","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00228-014-1797-4","article-title":"Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age","volume":"71","author":"Odsbu","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"14","key":"10.1016\/j.psym.2018.03.009_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJM197504032921405","article-title":"Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality","volume":"292","author":"Hartz","year":"1975","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.psym.2018.03.009_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00737-009-0100-7","article-title":"Zolpidem in Pregnancy: placental passage and outcome","volume":"12","author":"Juric","year":"2009","journal-title":"Arch Womens Ment Health"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/JCP.0b013e3182197055","article-title":"Are hypnotic benzodiazepine receptor agonists teratogenic in humans?","volume":"31","author":"Wikner","year":"2011","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.psym.2018.03.009_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bdra.20513","article-title":"and the National Birth Defects Prevention Study. Use of antihistamine medication during early pregnancy and isolate major malformations","volume":"85","author":"Gilboa","year":"2009","journal-title":"Birth Defects Res"},{"issue":"2","key":"10.1016\/j.psym.2018.03.009_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1081-1206(10)63385-6","article-title":"Prospective controlled study of hydroxyzine and cetirizine in pregnancy","volume":"78","author":"Einarson","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.psym.2018.03.009_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1067\/mai.2003.1499","article-title":"Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study","volume":"111","author":"Diav-Citrin","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mai.2003.130","article-title":"Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study","volume":"111","author":"Moretti","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.psym.2018.03.009_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.reprotox.2008.05.053","article-title":"The safety of cetirizine during pregnancy. A prospective observational cohort study","volume":"26","author":"Weber-Schoendorfer","year":"2008","journal-title":"Reprod Toxicol"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2007-994110","article-title":"Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis","volume":"14","author":"Seto","year":"1997","journal-title":"Am J Perinatol"},{"issue":"4","key":"10.1016\/j.psym.2018.03.009_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00003495-200059040-00005","article-title":"A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy","volume":"59","author":"Mazzota","year":"2000","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.psym.2018.03.009_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/tera.1420500105","article-title":"Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies","volume":"50","author":"Mckeigue","year":"1994","journal-title":"Teratology"},{"issue":"12","key":"10.1016\/j.psym.2018.03.009_bib36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00228-005-0055-1","article-title":"Use of antiemetic drugs during pregnancy in Sweden","volume":"61","author":"Asker","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7150\/ijms.3.106","article-title":"No increased risk of infant hypospadias after maternal use of loratadine in early pregnancy","volume":"3","author":"Kallen","year":"2006","journal-title":"Int J Med Sci"},{"issue":"6","key":"10.1016\/j.psym.2018.03.009_bib38","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaip.2013.07.008","article-title":"Assessment of antihistamine use in early pregnancy and birth defects","volume":"1","author":"Li","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/jmf.11.3.146.152","article-title":"Use of antihistamine drugs in early pregnancy and delivery outcome","volume":"11","author":"Kallen","year":"2002","journal-title":"J Maternal Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.psym.2018.03.009_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/bdra.22865","article-title":"and the National Birth Defects Prevention Study. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects","volume":"94","author":"Anderka","year":"2012","journal-title":"Birth Defects Res"},{"issue":"9","key":"10.1016\/j.psym.2018.03.009_bib41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10654-014-9925-0","article-title":"Early pregnancy exposure to antihistamines and risk of congenital heart defects: results of two case-control studies","volume":"29","author":"Smedt","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"10.1016\/j.psym.2018.03.009_bib42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1023\/A:1024891618953","article-title":"Delivery outcome after the use of meclozine in early pregnancy","volume":"18","author":"Kallen","year":"2003","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.psym.2018.03.009_bib43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/070674370905400405","article-title":"Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study","volume":"54","author":"Einarson","year":"2009","journal-title":"Can J Psychiatry"},{"issue":"2","key":"10.1016\/j.psym.2018.03.009_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/070674370304800207","article-title":"A multicenter prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy","volume":"48","author":"Einarson","year":"2003","journal-title":"Can J Psychiatry"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00737-015-0586-0","article-title":"Supplement use by women during pregnancy: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics","volume":"19","author":"Freeman","year":"2016","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psym.2018.03.009_bib46","doi-asserted-by":"crossref","unstructured":"Prazinko BF, Sam JA, Caldwell JL, Townsend AT. Dose uniformity of over-the-counter melatonin as determined by high pressure liquid chromatography; August 2000","DOI":"10.21236\/ADA383246"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.reprotox.2008.03.005","article-title":"Melatonin and pregnancy in the human","volume":"25","author":"Tamura","year":"2008","journal-title":"Reprod Toxicol"},{"issue":"3","key":"10.1016\/j.psym.2018.03.009_bib48","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1006\/bbrc.1998.9819","article-title":"Alteration by maternal pinealectomy of fetal and neonatal melatonin and dopamine D1 receptor binding in the suprachiasmatic nuclei","volume":"253","author":"Naitoh","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.psym.2018.03.009_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.02.040","article-title":"Potential adverse effects of antenatal melatonin as a treatment for intrauterine growth restriction: findings in pregnant sheep","volume":"215","author":"Gonzalez-Candia","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"7\u20138","key":"10.1016\/j.psym.2018.03.009_bib50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.etp.2011.01.011","article-title":"Adverse effects of melatonin on rat pups of Wistar-Kyoto dams receiving melatonin supplementation during pregnancy","volume":"64","author":"Singh","year":"2012","journal-title":"Exp Toxicol Pathol"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318218301646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318218301646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T07:13:20Z","timestamp":1570950800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318218301646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0033318218301646"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2018.03.009","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations in Treating Insomnia During Pregnancy: A Literature Review","name":"articletitle","label":"Article Title"},{"value":"Psychosomatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psym.2018.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}